Should You Avoid BioDelivery Sciences International, Inc. (BDSI)? – ArQule, Inc. (ARQL), Amicus Therapeutics, Inc. (FOLD)

Page 1 of 2

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) investors should pay attention to a decrease in support from the world’s most elite money managers in recent months.

BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

In today’s marketplace, there are tons of metrics shareholders can use to watch the equity markets. Some of the most underrated are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite hedge fund managers can outperform the market by a solid amount (see just how much).

Just as key, optimistic insider trading sentiment is another way to break down the stock market universe. Obviously, there are a variety of motivations for a bullish insider to sell shares of his or her company, but just one, very obvious reason why they would buy. Several empirical studies have demonstrated the valuable potential of this tactic if “monkeys” understand where to look (learn more here).

Consequently, it’s important to take a peek at the recent action surrounding BioDelivery Sciences International, Inc. (NASDAQ:BDSI).

What does the smart money think about BioDelivery Sciences International, Inc. (NASDAQ:BDSI)?

Heading into 2013, a total of 9 of the hedge funds we track were long in this stock, a change of -10% from one quarter earlier. With the smart money’s capital changing hands, there exists an “upper tier” of notable hedge fund managers who were boosting their holdings meaningfully.

According to our comprehensive database, Adage Capital Management, managed by Phill Gross and Robert Atchinson, holds the biggest position in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Adage Capital Management has a $10 million position in the stock, comprising 0% of its 13F portfolio. Sitting at the No. 2 spot is Julian Baker and Felix Baker of Baker Bros. Advisors, with a $9 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Remaining hedge funds that are bullish include Kevin Kotler’s Broadfin Capital, James E. Flynn’s Deerfield Management and Gregory Fraser, Rudolph Kluiber, and Timothy Kroch’s GRT Capital Partners.

Since BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has witnessed falling interest from hedge fund managers, it’s safe to say that there exists a select few money managers that slashed their positions entirely last quarter. Interestingly, Peter Algert and Kevin Coldiron’s Algert Coldiron Investors sold off the biggest stake of the “upper crust” of funds we watch, totaling close to $0 million in stock.. Mike Vranos’s fund, Ellington, also cut its stock, about $0 million worth. These transactions are interesting, as total hedge fund interest was cut by 1 funds last quarter.

How have insiders been trading BioDelivery Sciences International, Inc. (NASDAQ:BDSI)?

Insider buying is particularly usable when the company in question has experienced transactions within the past half-year. Over the latest six-month time frame, BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has experienced 2 unique insiders buying, and 2 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to BioDelivery Sciences International, Inc. (NASDAQ:BDSI). These stocks are Cytokinetics, Inc. (NASDAQ:CYTK), ArQule, Inc. (NASDAQ:ARQL), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Pain Therapeutics, Inc. (NASDAQ:PTIE), and Amicus Therapeutics, Inc. (NASDAQ:FOLD). This group of stocks are in the biotechnology industry and their market caps are similar to BDSI’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!